"build a large product portfolio......both Generic and OTC"The quote from Arun below (and posted by SW) I think holds PART of the answer to where NPH is going...
Arun
"We can source from various vendors as long as these organizations are approved from health Canada. This helps us to build a large product portfolio. Our competitors are mostly focused on Generics alone or OTC products alone. We see ourselves working towards both a Generic and OTC products company."
I am expecting rapid growth of this portfolia; but also as I said, adding in some very lucrative brand products as well., that from a bottom line profit stand point could have meaningfull large upside (this will be the cream that comes with the business model) ....I would not be surprised if the combined generic and OTC portfolio doubles again in the next 18 monthes, and I am basing this on expanding their existing relationships primarily.....and the clues that lead me to think this are there now ..JMHO...